I was standing at the coffee maker in the break room last spring when a colleague — I’ll call her J — mentioned she’d taken an Ambien the night before her day off. She said it the way you’d say you’d taken a multivitamin. No hedging, no lowered voice, no glance around to see who was listening. Just: “I finally slept. I took an Ambien. It was great.”
Nobody reacted. Nobody had anything to react to. J is a good nurse. She was off shift. She took a prescribed medication to sleep. That’s the whole story.
Two weeks later, in the same break room, a different colleague asked me — quietly, with the door closed — if it was true that I had “a card.” She’d heard something. She wanted to know if the rumor was real.
I want you to sit with those two scenes for a minute, because the distance between them is the entire subject of this article.
Ambien is a Schedule IV controlled substance. Its half-life is roughly two to three hours, but its effects on cognition and next-morning driving performance can persist for eight hours or longer, which is why the FDA revised its dosing guidance in 2013 to lower the recommended dose for women specifically. Ambien has been documented in cases of complex sleep behaviors — sleep-driving, sleep-eating, sleep-texting things you’d rather you hadn’t. It carries a boxed warning. It is, by any reasonable measure, a serious medication.
Nobody in my hospital whispers about Ambien.
The medical cannabis edible I keep in a locked box in my closet is a 5-milligram THC gummy. I take it on days off, sixteen hours or more before my next shift, to abort migraines I’ve been getting since I was twenty years old. The alternative is sumatriptan, which works on the headache but leaves me cognitively impaired for the next full day. I’ve written about that elsewhere.
The cannabis works better. It has a shorter functional window. It doesn’t leave me wrapped in wet cement the next morning. It is legal in North Dakota, prescribed by a certifying physician, dispensed by a licensed dispensary, and purchased with a state-issued card that has my photo on it.
My hospital’s policy treats it exactly the same as any other controlled substance. Don’t use it on shift. Don’t come to work impaired. Follow the same rules you’d follow for hydrocodone or a benzodiazepine.
That’s the policy. The culture is a different document entirely.
The culture is: J can talk about her Ambien at the coffee maker. I cannot talk about my edible anywhere on hospital property, and I’m writing this under a pseudonym because the space between hospital policy (which has caught up) and hospital culture (which has not) is where careers go to quietly end.
I want to be precise about what I am not saying. I am not saying Ambien is dangerous and cannabis is safe. I am not saying my colleagues shouldn’t take the medications their doctors prescribe. J’s Ambien use is her business, her doctor’s business, and none of mine. The entire point is that it should be none of mine. The entire point is that the mutual non-interference we extend to every other prescribed controlled substance breaks down at exactly one molecule, and the break is not pharmacological. It’s cultural.
Here is what I notice, working in an emergency department where I see the actual consequences of substance use every shift I work:
I have pushed naloxone on patients who overdosed on prescribed opioids. I have admitted patients for benzodiazepine withdrawal. I have cared for patients whose Ambien prescription was a factor in a motor vehicle accident. I have never — not once, in twelve years of ED nursing — admitted a patient for cannabis toxicity in a way that resembled any of the above. I have cared for people who consumed too much THC and felt terrible. They go home. They drink water. They sleep it off. It’s not nothing. But it’s not the same category of harm, and pretending it is does a disservice to the conversation.
None of this means cannabis is harmless. It isn’t. It has real effects on cognition, coordination, and judgment while you’re under its influence. That’s why the sixteen-hour rule exists. That’s why I don’t use it before shifts, during shifts, or the night before a shift. That’s why I treat it with the same clinical discipline I’d apply to any other impairing medication — because that’s what it is.
But the same is true of Ambien. And Ativan. And the hydrocodone in the break room lockbox that we hand out on discharge papers every single day.
So the question I’d like my colleagues to sit with — the ones who would raise an eyebrow if they learned about my card, the ones who whisper about other nurses who “apparently have one” — is not whether cannabis is acceptable. The policy has already answered that question. The question is why your reaction to a legally prescribed, responsibly used medication varies so dramatically based on which medication it is.
If you can articulate a pharmacological answer to that question, I’ll listen. I genuinely will.
If the answer is cultural — if it’s really about what cannabis used to mean, or what you were taught in DARE class in 1994, or what your mother-in-law would say if she found out — then I’d gently suggest that’s not a reason that holds up in a profession built on evidence.
We are allowed to update our thinking. We update our thinking about medications all the time. We used to give newborns sugar water. We used to put babies to sleep on their stomachs. We used to prescribe hormone replacement therapy like vitamins. We learned. We adjusted. The evidence moved and we moved with it.
The evidence on medical cannabis has moved. The policies have moved. The laws have moved.
The break room conversation hasn’t. Not yet.
But it could.